Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia

Patients with protracted sepsis develop impaired immunity, which predisposes them to acquiring secondary infections. One of the most common and lethal secondary infections is Pseudomonas aeruginosa pneumonia. Immunoadjuvant therapy is a promising approach to reverse sepsis-induced immunosuppression...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Leukoc Biol
Egile Nagusiak: Shindo, Yuichiro, Fuchs, Anja G., Davis, Christopher G., Eitas, Tim, Unsinger, Jacqueline, Burnham, Carey-Ann D., Green, Jonathan M., Morre, Michel, Bochicchio, Grant V., Hotchkiss, Richard S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society for Leukocyte Biology 2017
Gaiak:
Host Defense & Pathophysiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5235902/
https://ncbi.nlm.nih.gov/pubmed/27630218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.4A1215-581R
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak